Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Diagnostics company extends collaboration with Merck in Alzheimer research
October 6th, 2005
Celera Diagnostics, a joint venture between the Celera Genomics Group (CRA) and Applied Biosystems Group (ABI) of Applera Corp., announced the extension of its collaboration with Merck & Co., Inc., aimed at developing new treatments for Alzheimer disease. Under this collaboration, Celera Diagnostics and Merck will combine their research efforts in the genetics of this devastating brain disease to genetically validate and prioritize a series of genes targeted for drug development. The primary goal of the collaboration is to accelerate the discovery of new drugs to address the unmet clinical need for the treatment of Alzheimer. This collaboration follows the recent...
Source: Women's Health Weekly (2005-10-06)
|
